Effect of Metabolic Therapy in Patients With Chronic Ischemic Heart Disease

NCT00282360 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Coronary Artery Disease
Type II Diabetes Mellitus

Interventions

DRUG: Trimetazidine

Sponsor

IRCCS San Raffaele